Akebia Therapeutics, Inc.

Go to Akebia Therapeutics, Inc. Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$280.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company include...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast. The company said it sees full-year 2024 demand growth of 12% to 14% and revenue growth of 8% to 10% on a year-over-year basis, according to data from Benzinga Pro. RH shares jumped 9.4% to $324.99 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) rose 256.6% to $16.94 in pre-market trading after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. Binah Capital Group, Inc. (NASDAQ: BCG) gained 149% to $23.65 in pre-market trading after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 49.5% to $4.89 in pre-market trading. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares rose 36.3% to $0.1220 in pre-market ...

Related tickers: LGVN, CZOO, CC, MLKN, GCTS, PIK, XXII, MVLA, RH, ABTS, AKBA, BCG, GCT, NCNA, GMDA, HKIT, AVTX, UGRO, SOBR, KTRA.

Read Full Article

Akebia (AKBA) gains during premarket hours on Mar 28 as its key product Vafseo (vadadustat) tablets receive FDA's approval for the treatment of anemia due to chronic kidney disease.

Related tickers: ACET, ADMA, AKBA, FGEN.

Read Full Article
Trending Tickers
DATS

XNAS

$0.00
(%)
LASE

XNAS

$0.00
(%)
NYCB

XNYS

$0.00
(%)
PACW

XNAS

$0.00
(%)
MLGO

XNAS

$0.00
(%)